Merck has long been a pillar of stability in the pharmaceutical world, thanks in large part to the staggering success of its cancer drug Keytruda. But behind that success lies a quietly growing concern of what happens when the patents expire?
In a move that could reshape its future, Merck just announced a $10 billion acquisition of Verona Pharma.
» Read more about: 4% Dividend + 12x Earnings = Blockbuster in the Making »
BigBear.ai (NYSE: BBAI) has all the buzzwords that investors love these days AI, defense, government contracts but does that make it a great investment?
Some traders are hoping the stock will 3x but as any seasoned investor knows, hope isn’t a strategy. If you’re wondering what it would actually take to get there,
In the world of rideshare investing, Uber tends to get all the attention. And with autonomous driving hype swirling around Tesla, it’s easy to overlook the other major U.S. player in the space. But if you’re willing to dig deeper, Lyft (NASDAQ: LYFT) might just be one of the market’s most overlooked opportunities.
Lyft targets the $59.2B U.S.
» Read more about: Why Lyft Might Be The Highest Potential Stock Now »
The artificial intelligence gold rush has created winners and wannabes. Two companies at the center of that storm, C3.ai and CoreWeave, have taken very different paths in the race to capitalize on enterprise AI demand. Both play crucial roles in the AI stack, one builds the software brains, the other supplies the computational muscle. But only one of them has the market’s full attention.
Nvidia has been the undisputed king of the AI hardware empire.
But even monarchs can be overthrown, especially when their biggest allies start eyeing the throne.
Who’s threatening NVIDIA now and will they win?
Nvidia still leads AI hardware, but growth is slowing and major clients are building their own chips.
» Read more about: Nvidia Still Dominates AI, But the Ground Beneath It Is Shifting »
Datadog (NASDAQ: DDOG) is officially joining the S&P 500 on July 9. Shares are up by more than 15% since the announcement, adding to what’s already been a stunning multi-year run. Since going public six years ago, Datadog has skyrocketed by over 4x, nearly triple the S&P 500’s return over the same period.
But even after that massive run,
» Read more about: Datadog Just Cracked the S&P 500, Wall Street Thinks It’s Just Getting Started »
If someone told you the best way to invest in China’s booming AI ecosystem was through a 100-year-old South African media company, you’d probably do a double take. But here’s the thing that may actually be true, and it all comes down to Tencent and a few brilliantly timed decisions made more than two decades ago.
» Read more about: The Best Way to Bet on China’s AI Boom Might Just Be in South Africa »
It’s not every day you find a company bigger than Bank of America, American Express, and Goldman Sachs combined. Yet sitting near the top of the S&P 500 leaderboard is Mastercard (NYSE: MA), a payments powerhouse with a market cap hovering around half a trillion dollars.
In fact, Mastercard’s valuation puts it ahead of household names in finance and on par with tech icons,
» Read more about: Mastercard Might Be the Most Underrated $500 Billion Juggernaut in the Market »
When it comes to generating passive income, it’s easy to fall for the lure of high-yield dividend stocks but there’s often a catch with those eye-popping yields. Sometime, they signal companies that have maxed out their growth potential and are simply returning excess cash because they don’t have better places to put it.
That’s why seasoned investors sometimes prefer a different route,
» Read more about: Why This Dividend Growth ETF Might Be a Smarter Play Than Chasing High Yields »
NVDL is shorthand for the GraniteShares 2× Long NVDA Daily ETF, a leveraged fund that’s designed to return twice the daily performance of NVIDIA stock.
So, is NVDL a smart play or a high-voltage hazard?
Traders use NVDL to amplify short-term bets on NVIDIA without options or margin accounts.
» Read more about: Time to Buy Leveraged NVIDIA? The Double-Edged Sword »